Government of Sweden
Also known as: ALF Swedish Government Grant | County Council of Norrbotten, Sweden | County council of Östergötland | County Councils of Region Östergötland, Kalmar and Jönköping | FORTE | Håkan Hanberger | Jämtland County Council, Sweden | Jönköping county council | Katarina Hedin | Malmo Municipality, Sweden | Ministry of Health and Social Affairs, Sweden | NU-Hospital Organization, Sweden | Public Health Agency of Sweden | Region Jönköping County | Region Östergötland, Sweden | Region Värmland, Sweden | Region Västra Götaland, Sweden | Research, Education, Development & Innovation, Primary Health Care, Region Västra Götaland, Sweden | Stockholm County Council, Sweden | Swedish Armed Forces | Swedish International Development Cooperation Agency (SIDA) | Swedish National Board of Health and Welfare | Västernorrland County Council, Sweden
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2004Last known activity
Aug 6, 2025
Timeline
1900s
- Aug 1, 1905
Government of Sweden— Founded
Drugs by trial phase (44 distinct, 37 trials)
Phase 4 (15 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (12 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Studied for
- Alzheimer Disease
- Asphyxia
- Asphyxia Neonatorum
- Attention Deficit Disorder with Hyperactivity
- Birth Weight
- Communicable Diseases
- Compulsive Personality Disorder
- Cystic Fibrosis
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Disease
- Dysentery, Bacillary
- Dysmenorrhea
- Endometriosis
- Fetal Distress
- Fibrosis
- Graft vs Host Disease
- Heroin Dependence
- HIV Infections
- Hyperkinesis
- Hypersensitivity
- Infections
- Inflammation
- Insulin Resistance
- Neoplasms
- Obsessive-Compulsive Disorder
- Opioid-Related Disorders
- Pharyngitis
- Schizophrenia
- Snake Bites
- Substance-Related Disorders
- Tonsillitis
- Urinary Tract Infections
- Vitamin D Deficiency
Recent trials (45)
- NCT07199946CollaboratorPhase 1/Phase 2Aug 6, 2025
- NCT05688384Lead sponsorPhase 4Jan 19, 2023
- NCT05284552CollaboratorPhase 2Jul 12, 2022
- NCT05353829CollaboratorPhase 4Apr 28, 2022
- NCT05353829CollaboratorPhase 4Apr 28, 2022
- NCT05353829CollaboratorPhase 4Apr 28, 2022
- NCT05183178CollaboratorPhase 4Feb 1, 2022
- NCT05600517CollaboratorN/AAug 25, 2021
- NCT05600517CollaboratorN/AAug 25, 2021
- NCT04280731CollaboratorN/AJan 7, 2020
- NCT04083417Sponsor investigatorPhase 4Sep 30, 2019
- NCT04083417Overall official - principal investigatorPhase 4Sep 30, 2019
- NCT04083417Lead sponsorPhase 4Sep 30, 2019
- NCT04134130CollaboratorN/ASep 16, 2019
- NCT03982381CollaboratorPhase 4Sep 1, 2019
Details
- Founded
- Stockholm, SE Aug 1, 1905
- Last known activity
- Aug 6, 2025